| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |